retatrutide while pregnant vs. Tirzepatide: What's The Difference? – Forbes Health Retatrutide Side Effects and Safety:

Originally approved for type 2 diabetes and later for obesity treatment, GLP-1 and other incretin-based therapies have rapidly gained traction in both clinical and consumer spaces

Omzo's published materials describe an entirely online process - intake questionnaire, clinician review, prescription if approved, and medication delivery to your door

On average, GLP-1 use leads to a modest amount of weight loss, averaging between 5-10% of body weight, while some users may not experience any weight changes

10.1097/WNR.0b013e32832fbf14 20

Safety concerns with compounded drugs from 503A pharmacies often stem from a lack of adherence to pharmacy standards rather than the practice itself